Shinichi Ishihara

783 total citations
43 papers, 508 citations indexed

About

Shinichi Ishihara is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Shinichi Ishihara has authored 43 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 17 papers in Pulmonary and Respiratory Medicine and 15 papers in Oncology. Recurrent topics in Shinichi Ishihara's work include Lung Cancer Treatments and Mutations (14 papers), Spine and Intervertebral Disc Pathology (9 papers) and Lung Cancer Research Studies (8 papers). Shinichi Ishihara is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Spine and Intervertebral Disc Pathology (9 papers) and Lung Cancer Research Studies (8 papers). Shinichi Ishihara collaborates with scholars based in Japan, United States and Germany. Shinichi Ishihara's co-authors include Ryusei Saito, Koichi Minato, Kota Watanabe, Morio Matsumoto, Nobuyuki Fujita, Masatomo Mori, Mitsuru Yagi, Kyoichi Kaira, Takashi Tsuji and Noriko Yanagitani and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Spine.

In The Last Decade

Shinichi Ishihara

40 papers receiving 499 citations

Peers

Countries citing papers authored by Shinichi Ishihara

Since Specialization

Citations

This map shows the geographic impact of Shinichi Ishihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinichi Ishihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinichi Ishihara more than expected).

Fields of papers citing papers by Shinichi Ishihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinichi Ishihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinichi Ishihara. The network helps show where Shinichi Ishihara may publish in the future.

Co-authorship network of co-authors of Shinichi Ishihara

This figure shows the co-authorship network connecting the top 25 collaborators of Shinichi Ishihara. A scholar is included among the top collaborators of Shinichi Ishihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinichi Ishihara. Shinichi Ishihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparison of Surgical Outcomes After Posterior Decompression by Junior or Senior Surgeons for Patients With Cervical Ossification of the Posterior Longitudinal Ligament: Results From Retrospective Multicenter Cohort Study 2024 ·Global Spine Journal ·Toshiki Okubo, Narihito Nagoshi, Hitoshi Kono, Yoshiomi Kobayashi, Osahiko Tsuji, Ryoma Aoyama, Norihiro Isogai, Shinichi Ishihara, Kazuki Takeda, Masahiro Ozaki, Satoshi Suzuki, Morio Matsumoto, Masaya Nakamura, Kota Watanabe, Ken Ishii, Junichi Yamane	1
2	Minimally Invasive Spine Stabilization for Pyogenic Spondylodiscitis: A 23-Case Series and Review of Literature 2022 ·Medicina ·Shinichi Ishihara, Haruki Funao, Norihiro Isogai, Masayuki Ishihara, Takanori Saito, Ken Ishii	5
3	Metabolic Syndrome is a Predisposing Factor for Diffuse Idiopathic Skeletal Hyperostosis 2020 ·Neurospine ·Eijiro Okada, Shinichi Ishihara, Koichiro Azuma, Takehiro Michikawa, Satoshi Suzuki, Osahiko Tsuji, Satoshi Nori, Narihito Nagoshi, Mitsuru Yagi, Michiyo Takayama, Takashi Tsuji, Nobuyuki Fujita, Masaya Nakamura, Morio Matsumoto, Kota Watanabe	19
4	Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer 2020 ·Cancer Chemotherapy and Pharmacology ·Ou Yamaguchi, Hisao Imai, Hiroyuki Minemura, Kensuke Suzuki, (unknown), Yukihiro Umeda, Takashi Osaki, Norimitsu Kasahara, Junji Uchino, Tomohide Sugiyama, Shinichi Ishihara, Hisashi Ishii, Ichiro Naruse, Keita Mori, (unknown), Kenya Kanazawa, Koichi Minato, Hiroshi Kagamu, Kyoichi Kaira	39
5	Negative impact of spinal epidural lipomatosis on the surgical outcome of posterior lumbar spinous-splitting decompression surgery: a multicenter retrospective study 2019 ·The Spine Journal ·Nobuyuki Fujita, Shinichi Ishihara, Takehiro Michikawa, Satoshi Suzuki, Osahiko Tsuji, Narihito Nagoshi, Eijiro Okada, Mitsuru Yagi, Takashi Tsuji, Hitoshi Kono, Masaya Nakamura, Morio Matsumoto, Kota Watanabe	14
6	A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations 2018 ·Lung Cancer ·Hisao Imai, Kyoichi Kaira, Kensuke Suzuki, Masaki Anzai, (unknown), Tamotsu Ishizuka, (unknown), Ichiro Naruse, Kenji Nemoto, Junji Uchino, (unknown), Shinichi Ishihara, Koichi Minato, Takeshi Hisada	31
7	Onset and remodeling of coronal imbalance after selective posterior thoracic fusion for Lenke 1C and 2C adolescent idiopathic scoliosis (a pilot study) 2017 ·SHILAP Revista de lepidopterología ·Masayuki Ishikawa, Kai Cao, (unknown), Nobuyuki Fujita, Mitsuru Yagi, Naobumi Hosogane, Takashi Tsuji, Masafumi Machida, Shinichi Ishihara, Makoto Nishiyama, Yasuyuki Fukui, Masaya Nakamura, Morio Matsumoto, Kota Watanabe	17
8	First-line gefitinib treatment in elderly patients (aged ≥75 years) with non-small cell lung cancer harboring EGFR mutations 2015 ·Cancer Chemotherapy and Pharmacology ·(unknown), Hisao Imai, Tomomi Masuda, (unknown), (unknown), (unknown), Kyoichi Kaira, Mitsuyoshi Utsugi, Kimihiro Shimizu, Noriaki Sunaga, Yoshio Tomizawa, Shinichi Ishihara, Takao Ishizuka, Akira Mogi, Takeshi Hisada, Koichi Minato, Atsushi Takise, Ryusei Saito, Masanobu Yamada	17
9	A target-controlled infusion system with bispectral index monitoring of propofol sedation during endoscopic submucosal dissection 2014 ·SHILAP Revista de lepidopterología ·Atsushi Imagawa, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Hiroyuki Sakae, (unknown), (unknown), Hitomi Endo, (unknown), Shinichi Ishihara, Hiromitsu Kanzaki, (unknown), (unknown), Eisuke Kaji, (unknown), Masaharu Ando	10
10	Phase II study of oral S-1 plus cisplatin with bevacizumab for advanced non-squamous non-small cell lung cancer 2013 ·Lung Cancer ·Kyoichi Kaira, Yoshio Tomizawa, (unknown), (unknown), Akihiro Yoshii, (unknown), Yasuhiko Koga, Akihiro Ono, Takeshi Hisada, Koichi Minato, Koji Sato, (unknown), Shinichi Ishihara, (unknown), (unknown), Ryusei Saito, Noriaki Sunaga	7
11	Case Report: Malignant SFT of Pleura with Tendency for Rapid Growth 2012 ·Haigan ·Ryoichi Onozato, Shigebumi Tanaka, Yutaka Suzuki, (unknown), Shinichi Ishihara, Hiroyuki Kobayashi, Akira Mogi, Hiroyuki Kuwano	1
12	Impact of Preexisting Pulmonary Fibrosis Detected on Chest Radiograph and CT on the Development of Gefitinib-Related Interstitial Lung Disease 2008 ·American Journal of Clinical Oncology ·Yoichi Naito, Satoshi Tsuchiya, Shinichi Ishihara, Koichi Minato, Yoshinori Shitara, Atsushi Takise, Tatsuo Suga, Akira Mogi, (unknown), Ryusei Saito	21
13	A Phase I Dose Escalation Study of Biweekly Gemcitabine and Carboplatin in Completely Resected Stage IB-IIIA Nonsmall Cell Lung Cancer 2007 ·American Journal of Clinical Oncology ·Yoshio Tomizawa, Shinichi Ishihara, Hironobu Iijima, Hisao Imai, Koji Sato, Masakiyo Yatomi, (unknown), Hidenori Yamada, Go Kobayashi, Emi Ishida, (unknown), Haruka Aoki, Satoru Watanabe, Osamu Kawashima, Masatomo Mori, Ryusei Saito	4
14	[A case of pulmonary hypertrophic osteoarthropathy associated with primary lung cancer in a young adult successfully treated with gefitinib]. 2007 ·PubMed ·Hisao Imai, Yoshio Tomizawa, Shinichi Ishihara, Noriaki Sunaga, Haruka Aoki, Hironobu Iijima, (unknown), Satoru Watanabe, Ryusei Saito, Masatomo Mori	2
15	Two cases of acute hepatitis B complicated with amebic liver abscess 2006 ·Kanzo ·(unknown), Toshihiko Nagase, Taku Yasumoto, (unknown), (unknown), Shinichi Ishihara, Koji Nagaike, (unknown), (unknown), T Tsubakio	4
16	Association of the OGG1‐Ser326Cys polymorphism with lung adenocarcinoma risk 2006 ·Cancer Science ·Takashi Kohno, Hideo Kunitoh, Kaoru Toyama, Seiichiro Yamamoto, Aya Kuchiba, Daizo Saito, Noriko Yanagitani, Shinichi Ishihara, Ryusei Saito, Jun Yokota	66
17	Phase II study of weekly docetaxel and cisplatin in patients with non-small cell lung cancer 2005 ·Anti-Cancer Drugs ·Kyoichi Kaira, Atsushi Takise, Koichi Minato, (unknown), Shinichi Ishihara, (unknown), Satoshi Tsuchiya, Ryusei Saito, Koji Sato, Masatomo Mori	10
18	A Phase II Study of Combined Chemoradiotherapy for Limited Disease–Small-Cell Lung Cancer 2000 ·American Journal of Clinical Oncology ·Shinichi Ishihara, Satoshi Tsuchiya, Koichi Minato, Satoru Watanabe, Noriaki Sunaga, Koji Sato, Go Kobayashi, Hideki Hoshino, (unknown), (unknown), (unknown), (unknown), (unknown), Atsushi Takise, Ryusei Saito, Masatomo Mori	3
19	A Phase II Study of 72-Hour Continuous Infusion Consisting of Cisplatin and 5-Fluorouracil for Treatment of Non-Small Cell Lung Cancer 1995 ·Oncology ·Satoshi Tsuchiya, Koichi Minato, Hidehiko Nakano, Atsushi Takise, (unknown), (unknown), Hideki Hoshino, Ichiro Naruse, (unknown), (unknown), (unknown), Shinichi Ishihara, Masatomo Mori, Ryusei Saito	3
20	[Effects of 60-Co gamma-ray on pharmaceutical powders. II. On methyl linoleate mixed with lactose]. 1965 ·PubMed ·Tomoo Takahashi, Shinichi Ishihara	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact